Table 2.
Outcomes and adverse events
| N=19 | |
|---|---|
| Suspected infarct localisation, no./total no. (%) | |
| Anterior wall infarction | 9/19 (47%) |
| Posterior wall infarction | 10/19 (53%) |
| Pre-PCI TIMI grade flow*, no./total no. (%) | |
| 0 | 13/19 (68%) |
| 1 | 3/19 (16%) |
| 2 | 0 |
| 3 | 3/19 (16%) |
| Culprit lesion, no./total no. (%) | |
| No significant coronary stenosis | 3/19 (16%) |
| Left main artery | 1/19 (5%) |
| Left anterior descending artery | 9/19 (47%) |
| Circumflex artery | 2/19 (11%) |
| Right coronary artery | 4/19 (21%) |
| Post-PCI TIMI grade flow*, no./total no. (%) | |
| 0 | 1/19 (5%) |
| 1 | 0 |
| 2 | 1/19 (5%) |
| 3 | 17/19 (90%) |
| Peak level of creatine kinase, units/L (IQR)† | 3807 (1429–5585) |
| Peak level of troponin T, ng/mL (IQR)† | 4.56 (2.50–10.00) |
| Killip classification, no./total no. (%) | |
| I | 13/19 (68%) |
| II | 3/19 (16%) |
| III | 2/19 (11%) |
| IV | 1/19 (5%) |
| Recurrent ischaemia, no./total no. (%) | 0 |
| Major cardiac arrhythmias, no./total no. (%) | |
| Ventricular tachycardia | 2/19 (11%) |
| Ventricular fibrillation | 0 |
| Asystole | 0 |
| AV-Block ≥2° | 0 |
| Stroke | 0 |
| Major/minor bleeding§ | 0 |
| Cardiac arrest | 1/19 (5%) |
| Death | 1/19 (5%) |
| NYHA class at day 30§ | |
| I | 10/18 (56%) |
| II | 6/18 (33%) |
| III | 2/18 (11%) |
| IV | 0 |
| Infection within 30 days, no./total no. (%) | 3/19 (16%) |
*TIMI grade flow prior/after percutaneous coronary intervention.
†of 15 patients with percutaneous coronary intervention.
‡according to thrombolysis in myocardial infarction bleeding score.
§NYHA category of 18 patients survived to follow-up.
NYHA, New York Heat Association; PCI, percutaneous coronary intervention; TIMI, thrombolysis in myocardial infarction.